This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ionctura Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rebeca Zorrilla: Inventor in Pharmaceutical Research.
Introduction
Rebeca Zorrilla is an inventor associated with Geneva, Switzerland, and Ionctura SA. Her patent work concerns a PI3K-δ inhibitor intended for use in treatment regimens.
Latest Patents
Zorrilla is associated with 1 patent, titled “PI3K-δ inhibitor for use in treatment regimens.” The patent describes a compound, or a pharmaceutically acceptable salt of the compound, for treating diseases in which PI3Kδ pathway signaling is pathologically implicated, including cancer and inflammatory or autoimmune diseases. It specifies a dose and reports a favorable safety profile in humans, particularly regarding hepatotoxicity, diarrhea or colitis, respiratory infections, and hematologic toxicities.
Career Highlights
Her listed work connects her to pharmaceutical research and the development of treatment approaches involving PI3Kδ inhibition. The available information identifies Ionctura SA as her company.
Collaborations
Catherine Pickering and Zoë Johnson are listed as Zorrilla’s coworkers.
Conclusion
Rebeca Zorrilla’s patent activity centers on a PI3K-δ inhibitor and its potential use in treatment regimens, reflecting her connection to pharmaceutical innovation at Ionctura SA.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile